Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Acerus Pharmaceuticals Corp. buy tbackenh

Start price
€66.00
23.07.15 / 50%
Target price
€160.00
18.12.15
Performance (%)
-86.36%
End price
€9.00
18.12.15
Summary
This prediction ended on 18.12.15 with a price of €9.00. Massive losses of -86.36% were the result for the BUY prediction by tbackenh. tbackenh has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Acerus Pharmaceuticals Corp. - - - -
iShares Core DAX® 0.051% 5.593% 14.403% 19.767%
iShares Nasdaq 100 1.808% 7.445% 34.917% 57.237%
iShares Nikkei 225® 2.181% 2.815% 11.116% 8.873%
iShares S&P 500 1.040% 4.975% 27.631% 48.786%

Comments by tbackenh for this prediction

In the thread Acerus Pharmaceuticals Corp. diskutieren
Prediction Buy
Perf. (%) -86.36%
Target price 0.800
Change
Ends at 18.12.15

tbackenh stimmt der Outperform-Einschätzung der institutionellen Analysten zu

tbackenh stimmt am 23.07.2015 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 0.8€ zu.

Prediction Buy
Perf. (%) -86.36%
Target price 0.800
Change
Ends at 18.12.15

(Vom Mitglied beendet)